Literature DB >> 23664590

General intellectual ability does not explain the general deficit in schizophrenia.

Bradley E Gray1, Robert P McMahon, James M Gold.   

Abstract

Patients with schizophrenia demonstrate a generalized deficit across multiple cognitive domains. However, it is unknown whether this deficit is largely due to lower intelligence, or if there is an impact of schizophrenia which cannot be accounted for by measures of general intellectual ability (GIA). We created four IQ-matched strata of equal width between 89 healthy volunteers (HC) and 77 patients with schizophrenia (SZ) who had very similar IQ and reading scores within each stratum, then compared each stratum's performance on the MATRICS Consensus Cognitive Battery (MCCB). We hypothesized that any patient impairment on the MCCB after matching on IQ would be evidence that GIA does not fully explain the general deficit seen in schizophrenia. We found that patients showed evidence of greater neuropsychological impairment than what would be expected based solely on their IQ and reading ability scores. Further, this deficit was stronger in some cognitive domains than others, namely, processing speed and social cognition. These results suggest the presence of a distinction between GIA and generalized neuropsychological impairment that was consistent in magnitude across all patients, regardless of IQ.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23664590      PMCID: PMC3679318          DOI: 10.1016/j.schres.2013.04.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  11 in total

1.  Estimating and comparing univariate associations with application to the prediction of adult obesity.

Authors:  M S Pepe; R C Whitaker; K Seidel
Journal:  Stat Med       Date:  1999-01-30       Impact factor: 2.373

2.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Authors:  Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

3.  A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia.

Authors:  Mario Fioravanti; Olimpia Carlone; Barbara Vitale; Maria Elena Cinti; Linda Clare
Journal:  Neuropsychol Rev       Date:  2005-06       Impact factor: 7.444

4.  Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.

Authors:  Dwight Dickinson; Mary E Ramsey; James M Gold
Journal:  Arch Gen Psychiatry       Date:  2007-05

5.  General and specific cognitive deficits in schizophrenia.

Authors:  Dwight Dickinson; Virginia N Iannone; Christopher M Wilk; James M Gold
Journal:  Biol Psychiatry       Date:  2004-04-15       Impact factor: 13.382

6.  General and specific cognitive deficits in schizophrenia: Goliath defeats David?

Authors:  Dwight Dickinson; J Daniel Ragland; James M Gold; Ruben C Gur
Journal:  Biol Psychiatry       Date:  2008-05-09       Impact factor: 13.382

Review 7.  Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings.

Authors:  Abraham Reichenberg; Philip D Harvey
Journal:  Psychol Bull       Date:  2007-09       Impact factor: 17.737

8.  The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.

Authors:  Robert S Kern; Keith H Nuechterlein; Michael F Green; Lyle E Baade; Wayne S Fenton; James M Gold; Richard S E Keefe; Raquelle Mesholam-Gately; Jim Mintz; Larry J Seidman; Ellen Stover; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

9.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

Authors:  R W Heinrichs; K K Zakzanis
Journal:  Neuropsychology       Date:  1998-07       Impact factor: 3.295

Review 10.  The assessment of neuropsychological functioning in schizophrenia.

Authors:  Abraham Reichenberg
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

View more
  6 in total

1.  Influence of empathetic pain processing on cognition in schizophrenia.

Authors:  Kesong Hu; Marijn Lijffijt; Theodore P Beauchaine; Zhiwei Fan; Hui Shi; Shuchang He
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-12-05       Impact factor: 5.270

Review 2.  Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.

Authors:  James L Reilly; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-02-26       Impact factor: 9.306

Review 3.  Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.

Authors:  Douglas L Boggs; Jon Carlson; Jose Cortes-Briones; John H Krystal; D Cyril D'Souza
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Neurocognitive Decrements are Present in Intellectually Superior Schizophrenia.

Authors:  Anja Vaskinn; Torill Ueland; Ingrid Melle; Ingrid Agartz; Ole A Andreassen; Kjetil Sundet
Journal:  Front Psychiatry       Date:  2014-05-07       Impact factor: 4.157

5.  Facilitative Effects of Transcranial Direct Current Stimulation on Semantic Memory Examined by Text-Mining Analysis in Patients With Schizophrenia.

Authors:  Chika Sumiyoshi; Zui Narita; Takuma Inagawa; Yuji Yamada; Kazuki Sueyoshi; Yumi Hasegawa; Aya Shirama; Ryota Hashimoto; Tomiki Sumiyoshi
Journal:  Front Neurol       Date:  2021-02-11       Impact factor: 4.003

6.  Neurocognitive normality in schizophrenia revisited.

Authors:  R Walter Heinrichs; Farena Pinnock; Eva Muharib; Leah Hartman; Joel Goldberg; Stephanie McDermid Vaz
Journal:  Schizophr Res Cogn       Date:  2015-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.